Humans with obesity that have high levels of adiponectin are at lower risk of myocardial infarction, liver and kidney disease, and endometrial cancer (Turer & Scherer, 2012; Frühbeck et al, 2018). This evidence concerns the gene ADIPOQ and myocardial infarction.